Effects of cimetidine and ranitidine on splanchnic hemodynamics in patients with chronic liver disease. 1985

K Ohnishi, and T Nakayama, and M Saito, and H Hatano, and F Nomura, and S Iida, and K Okuda

Effects of two histamine H2 receptor antagonists, cimetidine and ranitidine, on systemic and splanchnic hemodynamics were studied in patients with chronic liver disease by simultaneous catheterization of the portal vein and the right hepatic vein and measurement of portal venous flow using the ultrasound doppler system or cineangiography. Neither infusion of 200 mg of cimetidine nor 50 mg of ranitidine reduced cardiac output, portal venous pressure, the gradient between wedged hepatic venous pressure and free hepatic venous pressure, hepatic blood flow, and portal venous flow. It is unlikely that histamine is an important modulator of flow via the H2 receptor.

UI MeSH Term Description Entries
D008102 Liver Circulation The circulation of BLOOD through the LIVER. Hepatic Circulation,Circulation, Liver,Circulation, Hepatic
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008297 Male Males
D011168 Portal System A system of vessels in which blood, after passing through one CAPILLARY BED, is conveyed through a second set of capillaries before it returns to the systemic circulation. It pertains especially to the hepatic portal system. Portal Systems,System, Portal,Systems, Portal
D011899 Ranitidine A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers. AH-19065,Biotidin,N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine,Ranisen,Ranitidin,Ranitidine Hydrochloride,Sostril,Zantac,Zantic,AH 19065,AH19065,Hydrochloride, Ranitidine
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D002927 Cimetidine A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. Altramet,Biomet,Biomet400,Cimetidine HCl,Cimetidine Hydrochloride,Eureceptor,Histodil,N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine,SK&F-92334,SKF-92334,Tagamet,HCl, Cimetidine,Hydrochloride, Cimetidine,SK&F 92334,SK&F92334,SKF 92334,SKF92334
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K Ohnishi, and T Nakayama, and M Saito, and H Hatano, and F Nomura, and S Iida, and K Okuda
April 1993, Zhonghua wai ke za zhi [Chinese journal of surgery],
K Ohnishi, and T Nakayama, and M Saito, and H Hatano, and F Nomura, and S Iida, and K Okuda
November 1994, Scandinavian journal of gastroenterology,
K Ohnishi, and T Nakayama, and M Saito, and H Hatano, and F Nomura, and S Iida, and K Okuda
December 1994, Internal medicine (Tokyo, Japan),
K Ohnishi, and T Nakayama, and M Saito, and H Hatano, and F Nomura, and S Iida, and K Okuda
November 1982, Deutsche medizinische Wochenschrift (1946),
K Ohnishi, and T Nakayama, and M Saito, and H Hatano, and F Nomura, and S Iida, and K Okuda
January 1990, European journal of clinical pharmacology,
K Ohnishi, and T Nakayama, and M Saito, and H Hatano, and F Nomura, and S Iida, and K Okuda
May 1983, Pharmacological research communications,
K Ohnishi, and T Nakayama, and M Saito, and H Hatano, and F Nomura, and S Iida, and K Okuda
September 1992, The American journal of gastroenterology,
K Ohnishi, and T Nakayama, and M Saito, and H Hatano, and F Nomura, and S Iida, and K Okuda
February 2000, World journal of gastroenterology,
K Ohnishi, and T Nakayama, and M Saito, and H Hatano, and F Nomura, and S Iida, and K Okuda
January 1985, Digestion,
K Ohnishi, and T Nakayama, and M Saito, and H Hatano, and F Nomura, and S Iida, and K Okuda
March 1982, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!